Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry

Simple item page
dc.contributor.authorKraft, Magdalena
dc.contributor.authorKnop, Macarena Pia
dc.contributor.authorRenaudin, Jean-Marie
dc.contributor.authorScherer Hofmeier, Kathrin
dc.contributor.authorPföhler, Claudia
dc.contributor.authorBilò, Maria Beatrice
dc.contributor.authorLang, Roland
dc.contributor.authorTreudler, Regina
dc.contributor.authorWagner, Nicola
dc.contributor.authorSpindler, Thomas
dc.contributor.authorHourihane, Jonathan O'B.
dc.contributor.authorMaris, Ioana
dc.contributor.authorKoehli, Alice
dc.contributor.authorBauer, Andrea
dc.contributor.authorLange, Lars
dc.contributor.authorMüller, Sabine
dc.contributor.authorPapadopoulos, Nikolaos G.
dc.contributor.authorWedi, Bettina
dc.contributor.authorMoeser, Anne
dc.contributor.authorEnsina, Luis F.
dc.contributor.authorFernandez-Rivas, Montserrat
dc.contributor.authorCichocka-Jarosz, Ewa
dc.contributor.authorChristoff, George
dc.contributor.authorGarcia, Blanca E.
dc.contributor.authorPoziomkowska-Gęsicka, Iwona
dc.contributor.authorCardona, Victoria
dc.contributor.authorMustakov, Tihomir B.
dc.contributor.authorRabe, Uta
dc.contributor.authorMahler, Vera
dc.contributor.authorGrabenhenrich, Linus
dc.contributor.authorDölle-Bierke, Sabine
dc.contributor.authorWorm, Margitta
dc.contributor.funderPomorski Uniwersytet Medyczny W Szczecinieen
dc.contributor.funderThe Network for Online Registration of Anaphylaxisen
dc.date.accessioned2019-12-09T09:38:22Z
dc.date.available2019-12-09T09:38:22Z
dc.date.issued2019-10-04
dc.description.abstractBackground: Patients with a history of anaphylaxis are at risk of future anaphylactic reactions. Thus, secondary prevention measures are recommended for these patients to prevent or attenuate the next reaction. Methods: Data from the Anaphylaxis Registry were analyzed to identify secondary prevention measures offered to patients who experienced anaphylaxis. Our analysis included 7788 cases from 10 European countries and Brazil. Results:The secondary prevention measures offered varied across the elicitors. A remarkable discrepancy was observed between prevention measures offered in specialized allergy centers (84% of patients were prescribed adrenaline autoinjectors following EAACI guidelines) and outside the centers: Here, EAACI guideline adherence was only 37%. In the multivariate analysis, the elicitor of the reaction, age of the patient, mastocytosis as comorbidity, severity of the reaction, and reimbursement/availability of the autoinjector influence physician's decision to prescribe one. Conclusions: Based on the low implementation of guidelines concerning secondary prevention measures outside of specialized allergy centers, our findings highlight the importance of these specialized centers and the requirement of better education for primary healthcare and emergency physicians.en
dc.description.sponsorshipClinical Allergology Department PMU in Szczecin (WL‐151‐19)en
dc.description.statusPeer revieweden
dc.description.versionPublished Versionen
dc.format.mimetypeapplication/pdfen
dc.identifier.citationKraft, M., Knop, M. P., Renaudin, J.-M., Scherer Hofmeier, K., Pföhler, C., Bilò, M. B., Lang, R., Treudler, R., Wagner, N., Spindler, T., Hourihane, J. O. B., Maris, I., Koehli, A., Bauer, A., Lange, L., Müller, S., Papadopoulos, N. G., Wedi, B., Moeser, A., Ensina, L. F., Fernandez-Rivas, M., Cichocka-Jarosz, E., Christoff, G., Garcia, B. E., Poziomkowska-Gęsicka, I., Cardona, V., Mustakov, T. B., Rabe, U., Mahler, V., Grabenhenrich, L., Dölle-Bierke, S., Worm, M. and Anaphylaxis, T. N. f. O. R. o. (2020) 'Secondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registry', Allergy, 75(4), pp.901-910. https://doi.org/10.1111/all.14069en
dc.identifier.doi10.1111/all.14069en
dc.identifier.endpage910en
dc.identifier.issn0105-4538
dc.identifier.issued4en
dc.identifier.journaltitleAllergy: European Journal of Allergy and Clinical Immunologyen
dc.identifier.startpage901en
dc.identifier.urihttps://hdl.handle.net/10468/9352
dc.identifier.volume75en
dc.language.isoenen
dc.publisherBlackwell Publishing Ltden
dc.rights©2019 The Authors. Allergy published by John Wiley & Sons Ltd.This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are madeen
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/en
dc.subjectAdrenaline autoinjectoren
dc.subjectAnaphylactic reactionen
dc.subjectAnaphylaxisen
dc.subjectEpinephrine autoinjectoren
dc.subjectSecondary preventionen
dc.subject~Public Health - Journal Articles~en
dc.subject~Paediatrics and Child Health - Journal Articles~en
dc.titleSecondary prevention measures in anaphylaxis patients: Data from the anaphylaxis registryen
dc.typeArticle (peer-reviewed)en
Files
Original bundle
Now showing 1 - 4 of 4
Thumbnail Image
Name:
Kraft_et_al-2019-Allergy.pdf
Size:
687.12 KB
Format:
Adobe Portable Document Format
Description:
Published version
Download
Thumbnail Image
Name:
Kraft_et_al-2019-Allergy.sup-1.pdf
Size:
30.82 KB
Format:
Adobe Portable Document Format
Description:
Supplementary file 1
Download
Thumbnail Image
Name:
Kraft_et_al-2019-Allergy.sup-2.pdf
Size:
63.99 KB
Format:
Adobe Portable Document Format
Description:
Supplementary file 2
Download
Thumbnail Image
Name:
all14069-sup-0003-TableS1-S2.docx
Size:
14.2 KB
Format:
Microsoft Word XML
Description:
Supplementary file 3
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
2.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
School of Public Health
School of Medicine